Cerner established a partnership with the Health Social Innovators programme to help healthcare start-ups develop their products and solutions into viable businesses. Health Social Innovators, a partnership between Healthbox, Numbers4Good, UCL Business, Trafford Housing Trust, Janssen Healthcare Innovation and established with support from the Cabinet Office under the Social Incubator Fund, launched its first accelerator programme for healthcare ventures with a social impact last week.

Allscripts (NASDAQ: MDRX) has introduced Sunrise Mobile Care™, a new mobile application for the Allscripts Sunrise EHR that delivers valuable medication, order and result information to the mobile devices of nurses and other clinicians.

Agfa HealthCare announces that it has been successfully installing two new DX-G digitizers and seven CR 30-X computed radiography (CR) systems as part of a digital radiography update at Salisbury NHS Foundation Trust. The digitizers support both standard phosphor plates and needle-based detectors, providing state-of-the-art image quality for the next generation in digital radiography across a broad range of applications.

MSC Cruises has become the first cruise line to offer a 24/7, multilingual pediatric telemedicine service on board its entire fleet thanks to an agreement with the renowned Instituto Giannina Gaslini Children's Hospital in Genoa, Italy.

Royal Philips (NYSE: PHG, AEX: PHIA) has reported Q3 sales of EUR 5.5 billion and operational results of EUR 536 million. Healthcare comparable sales grew by 1% year-on-year. The EBITA margin, excluding restructuring costs and various charges, was 12%, a decrease of 2.6 percentage points year-on-year.

Siemens Healthcare introduces the Symbia Evo Excel SPECT system at the 27th Congress of the European Association of Nuclear Medicine (EANM). The system is a new version of the successful Symbia E. Symbia Evo Excel combines industry-leading SPECT image resolution and detector sensitivity with the smallest room size requirement in its class*.

Royal Philips (NYSE: PHG, AEX: PHIA) has acquired the CE mark for diagnostic use of its Philips Digital Pathology Solution. European pathologists will now be able to use the full digital solution as an aid in diagnosis for routine pathology, such as primary diagnosis of oncology.